Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for Iovance Biotherapeutics (IOVA) over the last 2 years, with Dec 2024 value amounting to $289,877.

  • Iovance Biotherapeutics' Shares Outstanding (Diluted Average) rose 17.45% to $334,511 in Q2 2025 from the same period last year, while for Jun 2025 it was $334,511, marking a year-over-year increase of 17.45%. This contributed to the annual value of $289,877 for FY2024, which is 23.28% up from last year.
  • According to the latest figures from FY2024, Iovance Biotherapeutics' Shares Outstanding (Diluted Average) is $289,877, which was up 23.28% from $235,131 recorded in FY2023.
  • Iovance Biotherapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $289,877 for FY2024, and its period low was $235,131 during FY2023.
  • For the 2-year period, Iovance Biotherapeutics' Shares Outstanding (Diluted Average) averaged around $262,504, with its median value being $262,504 (2023).
  • Data for Iovance Biotherapeutics' Shares Outstanding (Diluted Average) shows a peak YoY climbed of 23.28% (in 2024) over the last 5 years.
  • Iovance Biotherapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $235,131 in 2023, then climbed by 23.28% to $289,877 in 2024.